AII American Integrity Insurance Group | $16.82 -14.2% | 5/13/2026 | | Lower Price Target | $28.00 ➝ $25.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of American Integrity Insurance Group (NYSE:AII) on 5/13/2026 |
ETOR eToro Group | $41.29 +9.8% | 5/13/2026 | | Boost Price Target | $85.00 ➝ $90.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of eToro Group (NASDAQ:ETOR) on 5/13/2026 |
IRD Opus Genetics | $5.03 -2.9% | 5/13/2026 | | Lower Price Target | $12.00 ➝ $11.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Opus Genetics (NASDAQ:IRD) on 5/13/2026 |
KLRS Kalaris Therapeutics | $4.83 +0.8% | 5/13/2026 | | Lower Price Target | $26.00 ➝ $25.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/13/2026 |
PHVS Pharvaris | $32.94 +5.4% | 5/13/2026 | | Lower Price Target | $75.00 ➝ $74.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Pharvaris (NASDAQ:PHVS) on 5/13/2026 |
GTM ZoomInfo Technologies | $3.96 -2.5% | 5/12/2026 | | Lower Price Target | $6.00 ➝ $2.50 | Market Underperform | 00.00% | View details for Citizens Jmp rating of ZoomInfo Technologies (NASDAQ:GTM) on 5/12/2026 |
MBX MBX Biosciences | $37.50 +1.4% | 5/12/2026 | | Boost Price Target | $76.00 ➝ $86.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of MBX Biosciences (NASDAQ:MBX) on 5/12/2026 |
EZPW EZCORP | $32.99 -1.7% | 5/11/2026 | | Boost Price Target | $33.00 ➝ $39.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of EZCORP (NASDAQ:EZPW) on 5/11/2026 |
PGNY Progyny | $23.51 +0.3% | 5/11/2026 | | Boost Price Target | $30.00 ➝ $31.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Progyny (NASDAQ:PGNY) on 5/11/2026 |
ABNB Airbnb | $132.97 -1.9% | 5/8/2026 | | Boost Price Target | $160.00 ➝ $170.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Airbnb (NASDAQ:ABNB) on 5/8/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AORT Artivion | $22.24 -3.7% | 5/8/2026 | | Lower Price Target | $53.00 ➝ $48.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Artivion (NYSE:AORT) on 5/8/2026 |
BLND Blend Labs | $1.47 +3.9% | 5/8/2026 | | Lower Price Target | $5.00 ➝ $4.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Blend Labs (NYSE:BLND) on 5/8/2026 |
CRNX Crinetics Pharmaceuticals | $37.48 +1.5% | 5/8/2026 | | Lower Price Target | $97.00 ➝ $95.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/8/2026 |
ENGN enGene | $1.54 +6.9% | 5/8/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Citizens Jmp rating of enGene (NASDAQ:ENGN) on 5/8/2026 |
KTOS Kratos Defense & Security Solutions | $52.49 -8.4% | 5/8/2026 | | Lower Price Target | $125.00 ➝ $105.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 5/8/2026 |
LNTH Lantheus | $96.46 +0.2% | 5/8/2026 | | Boost Price Target | $85.00 ➝ $115.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Lantheus (NASDAQ:LNTH) on 5/8/2026 |
OMDA Omada Health | $16.04 +7.6% | 5/8/2026 | | Boost Price Target | $18.00 ➝ $21.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Omada Health (NASDAQ:OMDA) on 5/8/2026 |
PCTY Paylocity | $104.23 -2.9% | 5/8/2026 | | Lower Price Target | $170.00 ➝ $150.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Paylocity (NASDAQ:PCTY) on 5/8/2026 |
PRTA Prothena | $9.60 +1.8% | 5/8/2026 | | Boost Price Target | $19.00 ➝ $20.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Prothena (NASDAQ:PRTA) on 5/8/2026 |
RKLB Rocket Lab | $124.15 +5.6% | 5/8/2026 | | Boost Price Target | $85.00 ➝ $95.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Rocket Lab (NASDAQ:RKLB) on 5/8/2026 |
UPWK Upwork | $8.39 +0.5% | 5/8/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Citizens Jmp rating of Upwork (NASDAQ:UPWK) on 5/8/2026 |
USPH U.S. Physical Therapy | $60.22 -1.0% | 5/8/2026 | | Lower Price Target | $113.00 ➝ $98.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of U.S. Physical Therapy (NYSE:USPH) on 5/8/2026 |
XMTR Xometry | $86.19 +2.7% | 5/8/2026 | | Boost Price Target | $75.00 ➝ $100.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Xometry (NASDAQ:XMTR) on 5/8/2026 |
AXON Axon Enterprise | $376.82 -4.3% | 5/7/2026 | | Lower Price Target | $825.00 ➝ $700.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Axon Enterprise (NASDAQ:AXON) on 5/7/2026 |
BCRX BioCryst Pharmaceuticals | $9.60 +9.1% | 5/7/2026 | | Boost Price Target | $25.00 ➝ $28.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2026 |
CCRN Cross Country Healthcare | $13.12
| 5/7/2026 | | Downgrade | | Strong-Buy ➝ Hold | 00.00% | View details for Citizens Jmp rating of Cross Country Healthcare (NASDAQ:CCRN) on 5/7/2026 |
DDOG Datadog | $205.31 +2.7% | 5/7/2026 | | Upgrade | $225.00 | Market Perform ➝ Outperform | 00.00% | View details for Citizens Jmp rating of Datadog (NASDAQ:DDOG) on 5/7/2026 |
ECPG Encore Capital Group | $79.02 -3.2% | 5/7/2026 | | Boost Price Target | $90.00 ➝ $108.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Encore Capital Group (NASDAQ:ECPG) on 5/7/2026 |
FLUT Flutter Entertainment | $95.02 -1.0% | 5/7/2026 | | Lower Price Target | $188.00 ➝ $165.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Flutter Entertainment (NYSE:FLUT) on 5/7/2026 |
HUT Hut 8 | $108.32 +0.9% | 5/7/2026 | | Boost Price Target | $100.00 ➝ $140.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Hut 8 (NASDAQ:HUT) on 5/7/2026 |
LIFE Ethos Technologies Inc. Class A Common Stock | $24.44 -4.7% | 5/7/2026 | | Boost Price Target | $21.00 ➝ $27.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) on 5/7/2026 |
NICE NiCE | $86.38 -0.4% | 5/7/2026 | | Lower Price Target | $200.00 ➝ $170.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of NiCE (NASDAQ:NICE) on 5/7/2026 |
RELY Remitly Global | $23.75 -0.5% | 5/7/2026 | | Boost Price Target | $22.00 ➝ $26.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Remitly Global (NASDAQ:RELY) on 5/7/2026 |
VEL Velocity Financial | $17.38 -0.1% | 5/7/2026 | | Boost Price Target | $22.00 ➝ $23.50 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Velocity Financial (NYSE:VEL) on 5/7/2026 |
ADUS Addus HomeCare | $94.51 -4.0% | 5/6/2026 | | Lower Price Target | $150.00 ➝ $142.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Addus HomeCare (NASDAQ:ADUS) on 5/6/2026 |
AVNW Aviat Networks | $15.35 +0.3% | 5/6/2026 | | Lower Price Target | $30.00 ➝ $25.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Aviat Networks (NASDAQ:AVNW) on 5/6/2026 |
AVTX Avalo Therapeutics | $19.85 -0.5% | 5/6/2026 | | Boost Price Target | $52.00 ➝ $62.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/6/2026 |
DAVE Dave | $240.07 -0.9% | 5/6/2026 | | Boost Price Target | $335.00 ➝ $365.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Dave (NASDAQ:DAVE) on 5/6/2026 |
HNGE Hinge Health | $54.00 -2.2% | 5/6/2026 | | Boost Price Target | $65.00 ➝ $80.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Hinge Health (NYSE:HNGE) on 5/6/2026 |
LMAT LeMaitre Vascular | $98.17 +1.0% | 5/6/2026 | | Boost Price Target | $118.00 ➝ $127.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of LeMaitre Vascular (NASDAQ:LMAT) on 5/6/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
MNTN MNTN | $7.85 -3.6% | 5/6/2026 | | Lower Price Target | $23.00 ➝ $19.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of MNTN (NYSE:MNTN) on 5/6/2026 |
PTGX Protagonist Therapeutics | $103.88 +3.9% | 5/6/2026 | | Boost Price Target | $120.00 ➝ $137.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/6/2026 |
SHOP Shopify | $95.40 -4.4% | 5/6/2026 | | Lower Price Target | $160.00 ➝ $150.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Shopify (NASDAQ:SHOP) on 5/6/2026 |
SPHR Sphere Entertainment | $131.57 -3.2% | 5/6/2026 | | Boost Price Target | $150.00 ➝ $175.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Sphere Entertainment (NYSE:SPHR) on 5/6/2026 |
BLZE Backblaze | $7.37 +4.8% | 5/5/2026 | | Reiterated Rating | $8.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Backblaze (NASDAQ:BLZE) on 5/5/2026 |
BMEA Biomea Fusion | $1.48 -6.3% | 5/5/2026 | | Initiated Coverage | $9.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Biomea Fusion (NASDAQ:BMEA) on 5/5/2026 |
JRVR James River Group | $4.10 -2.4% | 5/5/2026 | | Reiterated Rating | | Outperform ➝ Market Perform | 00.00% | View details for Citizens Jmp rating of James River Group (NASDAQ:JRVR) on 5/5/2026 |
NOW ServiceNow | $87.11 -2.1% | 5/5/2026 | | Reiterated Rating | $157.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of ServiceNow (NYSE:NOW) on 5/5/2026 |
VVX V2X | $70.56 +0.6% | 5/5/2026 | | Boost Price Target | $80.00 ➝ $90.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of V2X (NYSE:VVX) on 5/5/2026 |
CELC Celcuity | $124.47 -0.2% | 5/4/2026 | | Boost Price Target | $150.00 ➝ $160.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Celcuity (NASDAQ:CELC) on 5/4/2026 |
GOOGL Alphabet | $402.62 +3.9% | 5/4/2026 | | Boost Price Target | $385.00 ➝ $515.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Alphabet (NASDAQ:GOOGL) on 5/4/2026 |
MFA MFA Financial | $9.52 -0.5% | 5/4/2026 | | Boost Price Target | $11.00 ➝ $11.50 | Market Outperform | 00.00% | View details for Citizens Jmp rating of MFA Financial (NYSE:MFA) on 5/4/2026 |
CVNA Carvana | $69.83 -5.3% | 5/1/2026 | | Boost Price Target | $92.00 ➝ $103.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Carvana (NYSE:CVNA) on 5/1/2026 |
DBVT DBV Technologies | $19.60 -2.0% | 5/1/2026 | | Boost Price Target | $47.00 ➝ $55.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of DBV Technologies (NASDAQ:DBVT) on 5/1/2026 |
EBAY eBay | $113.01 +2.4% | 5/1/2026 | | Boost Price Target | $115.00 ➝ $120.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of eBay (NASDAQ:EBAY) on 5/1/2026 |
ESPR Esperion Therapeutics | $3.12 -0.3% | 5/1/2026 | | Downgrade | | Strong-Buy ➝ Hold | 00.00% | View details for Citizens Jmp rating of Esperion Therapeutics (NASDAQ:ESPR) on 5/1/2026 |
HG Hamilton Insurance Group | $30.22 -1.6% | 5/1/2026 | | Boost Price Target | $36.00 ➝ $38.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Hamilton Insurance Group (NYSE:HG) on 5/1/2026 |
NMRK Newmark Group | $15.84 -1.9% | 5/1/2026 | | Boost Price Target | $21.00 ➝ $22.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Newmark Group (NASDAQ:NMRK) on 5/1/2026 |
NTSK Netskope | $10.56 -2.3% | 5/1/2026 | | Lower Price Target | $23.00 ➝ $17.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Netskope (NASDAQ:NTSK) on 5/1/2026 |
RDDT Reddit | $154.55 +1.4% | 5/1/2026 | | Lower Price Target | $250.00 ➝ $240.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Reddit (NYSE:RDDT) on 5/1/2026 |
ROKU Roku | $125.68 -1.5% | 5/1/2026 | | Boost Price Target | $160.00 ➝ $170.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Roku (NASDAQ:ROKU) on 5/1/2026 |
TWLO Twilio | $192.80 +0.0% | 5/1/2026 | | Boost Price Target | $185.00 ➝ $210.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Twilio (NYSE:TWLO) on 5/1/2026 |
ZS Zscaler | $152.43 +4.3% | 5/1/2026 | | Lower Price Target | $290.00 ➝ $210.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Zscaler (NASDAQ:ZS) on 5/1/2026 |
ALKT Alkami Technology | $16.57 -1.3% | 4/30/2026 | | Lower Price Target | $28.00 ➝ $23.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Alkami Technology (NASDAQ:ALKT) on 4/30/2026 |
LMND Lemonade | $53.01 -3.9% | 4/30/2026 | | Lower Price Target | $85.00 ➝ $80.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Lemonade (NYSE:LMND) on 4/30/2026 |
MDXG MiMedx Group | $3.52 -0.6% | 4/30/2026 | | Lower Price Target | $7.00 ➝ $6.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of MiMedx Group (NASDAQ:MDXG) on 4/30/2026 |
RRR Red Rock Resorts | $51.04 -3.8% | 4/30/2026 | | Lower Price Target | $71.00 ➝ $67.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Red Rock Resorts (NASDAQ:RRR) on 4/30/2026 |
THG The Hanover Insurance Group | $188.99 -0.3% | 4/30/2026 | | Boost Price Target | $200.00 ➝ $205.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of The Hanover Insurance Group (NYSE:THG) on 4/30/2026 |
AMT American Tower | $174.04 -2.7% | 4/29/2026 | | Reiterated Rating | $260.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of American Tower (NYSE:AMT) on 4/29/2026 |
AXGN AxoGen | $40.29 -1.6% | 4/29/2026 | | Boost Price Target | $42.00 ➝ $50.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of AxoGen (NASDAQ:AXGN) on 4/29/2026 |
BRZE Braze | $19.43 +0.9% | 4/29/2026 | | Reiterated Rating | $35.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Braze (NASDAQ:BRZE) on 4/29/2026 |
CSGP CoStar Group | $31.97 -3.3% | 4/29/2026 | | Lower Price Target | $73.00 ➝ $44.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of CoStar Group (NASDAQ:CSGP) on 4/29/2026 |
CZR Caesars Entertainment | $26.79 +5.4% | 4/29/2026 | | Boost Price Target | $34.00 ➝ $35.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Caesars Entertainment (NASDAQ:CZR) on 4/29/2026 |
GLXY Galaxy Digital | $30.81 -1.8% | 4/29/2026 | | Reiterated Rating | $55.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Galaxy Digital (NASDAQ:GLXY) on 4/29/2026 |
HOOD Robinhood Markets | $76.75 -1.9% | 4/29/2026 | | Reiterated Rating | $155.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Robinhood Markets (NASDAQ:HOOD) on 4/29/2026 |
KALV KalVista Pharmaceuticals | $26.80 +0.3% | 4/29/2026 | | Downgrade | | Strong-Buy ➝ Hold | 00.00% | View details for Citizens Jmp rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 4/29/2026 |
PCOR Procore Technologies | $46.11 -4.1% | 4/29/2026 | | Upgrade | $71.00 | Market Perform ➝ Market Outperform | 00.00% | View details for Citizens Jmp rating of Procore Technologies (NYSE:PCOR) on 4/29/2026 |
SPOT Spotify Technology | $430.63 -0.5% | 4/29/2026 | | Reiterated Rating | $800.00 ➝ $600.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Spotify Technology (NYSE:SPOT) on 4/29/2026 |
ZBH Zimmer Biomet | $82.67 -0.8% | 4/29/2026 | | Lower Price Target | $120.00 ➝ $105.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Zimmer Biomet (NYSE:ZBH) on 4/29/2026 |
BL BlackLine | $25.23 -3.7% | 4/28/2026 | | Reiterated Rating | $70.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of BlackLine (NASDAQ:BL) on 4/28/2026 |
CMPX Compass Therapeutics | $1.97 +5.3% | 4/28/2026 | | Reiterated Rating | $10.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Compass Therapeutics (NASDAQ:CMPX) on 4/28/2026 |
CRMD CorMedix | $7.50 -0.1% | 4/28/2026 | | Reiterated Rating | $19.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of CorMedix (NASDAQ:CRMD) on 4/28/2026 |
CRNX Crinetics Pharmaceuticals | $37.48 +1.5% | 4/28/2026 | | Boost Price Target | $96.00 ➝ $97.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 4/28/2026 |
IRD Opus Genetics | $5.03 -2.9% | 4/28/2026 | | Initiated Coverage | $12.00 | Market Perform | 00.00% | View details for Citizens Jmp rating of Opus Genetics (NASDAQ:IRD) on 4/28/2026 |
NTLA Intellia Therapeutics | $14.28 +2.1% | 4/28/2026 | | Boost Price Target | $28.00 ➝ $30.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Intellia Therapeutics (NASDAQ:NTLA) on 4/28/2026 |
RLAY Relay Therapeutics | $13.22 +2.2% | 4/28/2026 | | Boost Price Target | $17.00 ➝ $19.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Relay Therapeutics (NASDAQ:RLAY) on 4/28/2026 |
TYL Tyler Technologies | $298.51 -3.6% | 4/28/2026 | | Reiterated Rating | $500.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Tyler Technologies (NYSE:TYL) on 4/28/2026 |
UBER Uber Technologies | $74.77 -2.1% | 4/28/2026 | | Reiterated Rating | $100.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Uber Technologies (NYSE:UBER) on 4/28/2026 |
CELC Celcuity | $124.47 -0.2% | 4/27/2026 | | Initiated Coverage | $150.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Celcuity (NASDAQ:CELC) on 4/27/2026 |
DLR Digital Realty Trust | $193.06 -1.1% | 4/27/2026 | | Boost Price Target | $220.00 ➝ $250.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Digital Realty Trust (NYSE:DLR) on 4/27/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
HURA TuHURA Biosciences | $2.51 +3.7% | 4/27/2026 | | Initiated Coverage | $9.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of TuHURA Biosciences (NASDAQ:HURA) on 4/27/2026 |
KREF KKR Real Estate Finance Trust | $6.44 +0.5% | 4/27/2026 | | Downgrade | | Outperform ➝ Market Perform | 00.00% | View details for Citizens Jmp rating of KKR Real Estate Finance Trust (NYSE:KREF) on 4/27/2026 |
CHDN Churchill Downs | $85.56 -1.2% | 4/24/2026 | | Boost Price Target | $146.00 ➝ $149.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Churchill Downs (NASDAQ:CHDN) on 4/24/2026 |
ENVA Enova International | $163.36 -2.1% | 4/24/2026 | | Boost Price Target | $182.00 ➝ $195.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Enova International (NYSE:ENVA) on 4/24/2026 |
NOW ServiceNow | $87.11 -2.1% | 4/23/2026 | | Lower Price Target | $260.00 ➝ $157.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of ServiceNow (NYSE:NOW) on 4/23/2026 |
STRO Sutro Biopharma | $39.60 -3.2% | 4/23/2026 | | Boost Price Target | $35.00 ➝ $41.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Sutro Biopharma (NASDAQ:STRO) on 4/23/2026 |
ARCC Ares Capital | $18.78 +0.1% | 4/22/2026 | | Lower Price Target | $23.00 ➝ $22.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Ares Capital (NASDAQ:ARCC) on 4/22/2026 |
ARES Ares Management | $123.31 -0.3% | 4/22/2026 | | Lower Price Target | $205.00 ➝ $190.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Ares Management (NYSE:ARES) on 4/22/2026 |
BX Blackstone | $119.63 -2.5% | 4/22/2026 | | Lower Price Target | $195.00 ➝ $190.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Blackstone (NYSE:BX) on 4/22/2026 |
CB Chubb | $315.93 -1.9% | 4/22/2026 | | Boost Price Target | $350.00 ➝ $365.00 | Market Outperform | 00.00% | View details for Citizens Jmp rating of Chubb (NYSE:CB) on 4/22/2026 |